• 1
    Mosmann, T. R. and Sad, S., The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 1996. 17: 138146.
  • 2
    Romagnani, S., Lymphokine production by human T cells in disease states. Annu. Rev. Imunol. 1994. 12: 227257.
  • 3
    Abbas, A. K., Murphy, K. M. and Sher, A., Functional diversity of helper T lymphocytes. Nature 1996. 383: 787793.
  • 4
    Paul, W. E. and Seder, R. A., Lymphocyte responses and cytokines. Cell 1994. 76: 241251.
  • 5
    Kapsenberg, M. L., Jansen, H. M., Bos, J. D. and Wierenga, E. A., Role of type 1 and type 2 T helper cells in allergic diseases. Curr. Opin. Immunol .1992. 4: 788794.
  • 6
    Holt, P. G., Key factors in the development of asthma: atopy. Am. J. Respir. Crit. Care Med. 2000. 161: 172175.
  • 7
    Simon, H. U. and Blaser, K., Inhibition of programmed eosinophil death: a key of pathogenic event for eosinophilia? Immunol. Today 1995. 16: 5355.
  • 8
    Spiegelberg, H. L., Beck, L., Kocher, H. P., Fanslow, W. C. and Lucas, A. H., Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice. J. Clin. Invest .1994. 93: 711717.
  • 9
    Punnonen, J., Aversa, G., Cocks, B. G., Mc Kenzie, A. N. J., Menon, S., Zurawski, G., De Waal Malefyt, R. and De Vries, J. E., Interleukin-13 induces interleukin-4 independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci U S A 1993. 90: 37303734.
  • 10
    Hamelmann, E. and Gelfand, E. W., IL-5-induced airway eosinophila — the key to asthma? Immunol. Rev. 2001. 179: 182191.
  • 11
    Aalberse, R. C., van der Gaag, R. and van Leuwen, J., Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J. Immunol. 1983. 130: 722726.
  • 12
    Akdis, C. A., Blesken, T., Akdis, M., Alkan, S. S., Wüthrich, B., Heusser, C. H. and Blaser, K., Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells. J. Allergy Clin. Immunol .1997. 99: 345353.
  • 13
    Carballido, J. M., Carballido-Perrig, N., Oberli-Schrämmli, A., Heusser, C. H. and Blaser, K., Regulation of IgE and IgG4 responses by allergen-specific T-cell clones to bee venom phospholipase A2 in vitro. J. Allergy Clin. Immunol .1994. 93: 758767.
  • 14
    Punnonen, J. R., de Waal Malefyt, R., van Vlasserlaer, P., Gauchat, J. F. and De Vries, J. E., IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J. Immunol .1993. 151: 12801289.
  • 15
    Akdis, C. A., Blesken, T., Akdis, M., Wuthrich, B. and Blaser, K., The role of IL-10 in specific immunotherapy. J. Clin. Invest. 1998. 102: 98106.
  • 16
    Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M. and O'Garra, A., IL-10 inhibits cytokine production by activated macrophages. J. Immunol .1991. 147: 38153822.
  • 17
    De Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G. and de Vries, J. E., Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991. 174: 12091220.
  • 18
    Hsu, D. H., Moore, K. W. and Spits, H., Differential effects of interleukin-4 and -10 on interleukin-2 induced interferon-γ synthesis and lymphokine activated killer activity. Int. Immunol. 1992. 4: 563569.
  • 19
    Del Prete, G., DeCarli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R. and Romagnani, S., Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993. 150: 353360.
  • 20
    Schandene, L., Alonso-Vega, C., Willems, F., Gerard, C., Delvaux, A., Velu, T., Devos, R., de Boer, M. and Goldman, M., B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 1994. 152: 43684374.
  • 21
    Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B. and Fauci, A. S., Production of transforming growth facor-β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 1986. 163: 10371050.
  • 22
    Schmitt, E., Hoen, P., Huels, C., Goedert, S., Palm, N., Rude, E. and German, T., T helper type I development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-β. Eur. J. Immunol .1994. 24: 793799.
  • 23
    Fargeas, C., Wu, C.Y., Nakajima, T., Cox, D., Nutman, T. and Delespesse, G., Differential effect of transforming growth factor-β on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes. Eur. J. Immunol. 1992. 22: 21732176.
  • 24
    Nagelkerten, L., Gollob, K. J., Tielemans, M. and Coffman, R., Roleof transforming growth factor-β in the preferential induction of T helper cells of type 1 by staphyloccocal enterotoxin B. Eur. J. Immunol. 1993. 23: 23062310.
  • 25
    Ludviksson, B. R., Seegers, D., Resnick, A. S. and Strober, W., Theeffect of TGF-β1 on immune responses of naive versus memory CD4+ Th1/Th2 cells. Eur. J. Immunol. 2000. 30: 21012111.
  • 26
    Zhang, X., Giangreco, L., Broome, H. E., Dargan, C. M. and Swain, S. L., Control of CD4 effector fate: transforming growth factor-β1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J. Exp.Med. 1995. 182: 699709.
  • 27
    Geiser, A. G., Letterio, J. J., Kulkarni, A. B., Karlsson, S., Roberts, A. B. and Sporn, M. B., Transforming growth factor-β1 (TGF-β1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatiblity antigen expression in the pathogenesis of the TGF-β1 null mouse phenotype. Proc. Natl. Acad. Sci. U S A 1993. 90: 99449948.
  • 28
    Takeuchi, M., Alard, P. and Streilein, J. W., TGF-β promotes immune deviationby altering accessory signals of antigen presenting cell. J. Immunol. 1998. 160: 15891597.
  • 29
    Letteiro, J. J. and Roberts, A. B., Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 1998. 16: 137161.
  • 30
    Cazac, B. B. and Roes, J., TGFβ receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 2000. 13: 443451.
  • 31
    Secrist, H., Chelen, C. J., Wen, Y., Marshall, J. D. and Umetsu, D. T., Allergen immunotherapy decreases interleukin 4 production in CD4 T cells from allergic individuals. J. Exp. Med. 1993. 178: 21232130.
  • 32
    Varney, V. A., Hamid, Q. A., Gaga, M., Ying, S., Jacobson, M., Frew, A. J., Kay, A. B. and Durham, S. R., Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late phase cutaneos responses. J. Clin. Invest. 1993. 92: 644651.
  • 33
    Jutel, M., Pichler, W. J., Skrbic, D., Urwyler, A., Dahinden, C. and Müller, U. R., Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen stimulated T cell cultures. J. Immunol. 1995. 154: 41874194.
  • 34
    Lack, G., Nelson, H. S., Amran, D., Oshiba, A., Jung, T., Bradley, K. L., Giclas, P. C. and Gelfand, E. W., Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-γ production in CD4+ T cells. J. Allergy Clin. Immunol. 1997. 99: 530538.
  • 35
    Bellinghousen, I., Metz, G., Enk, A. H., Christmann, S., Knop, J. and Saloga, J., Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur. J. Immunol .1997. 27: 11311139.
  • 36
    Akdis, A. C., Akdis, M., Blesken, T., Wymann, D., Alkan, S. S. and Blaser, K., Epitope specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 1996. 98: 16761683.
  • 37
    Akdis, C. A., Joss, A., Akdis, M., Faith, A. and Blaser, K., A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J .2000. 14: 16661668.
  • 38
    Akdis, C. A. and Blaser, K., IL-10 induced peripheral T cell anergy and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J. 1999. 13: 603609.
  • 39
    Durham, S. R., Walker, S. M., Varga, E. M., Jacobson, M. R., O'Brien, F., Noble, W., Till, S. J., Hamid, Q. A. and Nouri-Aria, K. T., Long-term clinical efficacy of grass-pollen immunotherapy. N. Engl. J. Med. 1999. 341: 468475.
  • 40
    Parker, W. A., Whisman, B. A., Apalinski, S. J. and Reid, M. J., The relationship between cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis. J. Allergy Clin. Immunol .1989. 84: 667677.
  • 41
    Creticos, P. S., The consideration of immunotherapy in the treatment of allergic asthma. J. Allergy Clin. Immunol. 2000. 105: 559579.
  • 42
    Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self tolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 11511156.
  • 43
    Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E. and Roncarolo, M. G., A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997. 389: 737742.
  • 44
    Read, S. and Powrie, F., CD4(+) regulatory T cells. Curr. Opin. Immunol. 2001. 13: 644649.
  • 45
    Shevach, E. M., Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 2000. 18: 423449.
  • 46
    Suri-Payer, E., Amar, A. Z., Thornton, A. M. and Shevach, E. M., CD4+ CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 1998. 160: 12121218.
  • 47
    Thornton, A. M. and Shevach, E. M., CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287296.
  • 48
    Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J. and Enk, A, H., Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolatedfrom peripheral blood. J. Exp. Med. 2001. 193:12851294.
  • 49
    Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F. and D' Ambrosio, D., Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells. J. Exp. Med. 2001. 194: 847853.
  • 50
    Annuziato, F., Cosmi, L., Liotta, F., Lazzeri, E., Manetti, R., Vanini, V., Romagnani, P., Maggi, E. and Romagnani, S., Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes. J. Exp. Med. 2002. 196: 379387.
  • 51
    Vignola, A. M., Chanez, P., Chiappara, G., Meredino, A., Pace, E., Rizzo, A., LaRocca, A. M., Bellia, V., Bonsignore, G. and Bousquet, J., Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med. 1997. 156: 591599.
  • 52
    Magnan, A., Retornaz, F., Tsicopoulos, A., Brisse, J., Van Pee, D., Gosse, P., Chamlian, A., Tonnel, A. B. and Vervloet, D., Altered compartmenalization of transforming growth factor-β in asthmatic airways. Clin. Exp. Allergy 1997. 27: 389395.
  • 53
    Fukaura, H., Kent, S. C., Pietrusewicz, M. J., Khoury, S. J., Weiner, H. L. and Hafler, D. A., Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 1996. 98: 7077.
  • 54
    Inobe, J., Slavin, A. J., Komagata, Y., Chen, Y., Liu, L. and Weiner, H. L., IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 1998. 28: 27802790.
  • 55
    Liu, Y., de Waal Malefyt, R., Briere, F., Parham, C., Bridon, J. M., Banchereau, J., Moore, K. W. and Xu, J., The Epstein-Barr virus interleukin-10 (IL-10) homolog is a selective agonist with impaired binding to the IL-10 receptor. J. Immunol. 1997. 158: 604613.
  • 56
    Taams, L. S., Smith, J., Rustin, M. H., Salmon, M., Poulter,L. W. and Akbar, A. N., Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 2001. 31: 11221231.
  • 57
    Jonuleit, H., Schmitt, E., Kakirman, H., Stassen, M., Knop, J. and Enk, A. H., Infectious tolerance: human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells. J. Exp. Med. 2002. 196: 255260.